An interventional study of Personalized Attention Bias Training and Neutral Attention Training Condition in Post Traumatic Stress Disorder, sponsored by University of California, San Francisco. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by University of California, San Francisco · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Stress Disorders, Post-Traumatic by University of California, San Francisco — 2 open to participants now, 2 under way, none of them phase 3. Stress Disorders, Post-Traumatic · University of California, San Francisco.
Among the 17 studies in Stress Disorders, Post-Traumatic by University of California, San Francisco, this one is the 3rd largest by enrollment of the 14 interventional ones that give a count, is the only one that started in 2017, is one of 9 with no phase, and was the 12th registered.
2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.
Browse Stress Disorders, Post-Traumatic studies →2 of the 17 studies in Stress Disorders, Post-Traumatic by University of California, San Francisco are open now, in 1 country. Recruiting first, the newest first:
University of California, San Francisco · Sites in United States
Ages 18–65 · Healthy volunteers
University of California, San Francisco · Sites in United States
Ages 18+ · Healthy volunteers
By country, each count listing its studies:
Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 1 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 689 is above the median of 69 across 2,203 interventional studies indexed under Stress Disorders, Post-Traumatic.
Median enrollment 74 across the 14 interventional studies, 100,004 across the 2 observational. Of the 14 that completed or were terminated, 8 (57%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of California, San Francisco is the lead sponsor of 2,172 studies on the registry; 370 are open to participants now.
Of its 269 completed or terminated interventional studies of FDA-regulated products, 203 (75%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 17 studies in Stress Disorders, Post-Traumatic by University of California, San Francisco, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The investigators have developed a mobile app called Resolving Psychological Stress (REPS) for people with posttraumatic stress disorder (PTSD). The app will administer threat-related attention bias modification to individuals who score high on a PTSD checklist. This study will be administered remotely to individuals in the United States. The aims of the study are to explore feasibility, acceptability and usability of the app in an entirely remote study, as well as to explore the efficacy of the app at reducing attention bias and PTSD symptom severity.
Posttraumatic stress disorder (PTSD) is a highly disabling disorder that affects approximately 8% of the population worldwide. Threat-related attention biases represent an important mechanism that may underlie PTSD symptoms. Such attention biases predict risk for PTSD following trauma exposure, and are thought to maintain some symptoms of PTSD. Research indicates that specific forms of computerized attention bias modification (ABM) training are effective in reducing attention bias for threat. We have developed a mobile app called REPS (Resolving Psychological Stress) to administer threat-related ABM training to people with symptoms of PTSD and have tested it in a laboratory-based pilot study of 22 people with elevated PTSD symptoms. Our preliminary data indicate that the app is highly acceptable to patients and that use of the app reduces attention bias for threat and PTSD symptom severity. The proposed study will expand on this prior lab-based study to test ABM training on an app entirely remotely. Our primary aim is to examine the feasibility, acceptability and usability of remotely administered app-based ABM training and to determine the efficacy of remote app-based ABM training in reducing attention bias and PTSD symptom severity. Our secondary aim is to examine whether a personalized version of ABM training results in greater attentional bias change and anxiety reduction compared to a non-personalized ABM training.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Personalized version of ABM Training.
Device: Personalized Attention Bias Training
Non-active version of ABM training.
Device: Neutral Attention Training Condition
Non-personalized version of ABM training.
Device: Non-Personalized Attention Bias Training
This self-help program will aim to reduce neurobiological threat sensitivity with the ultimate goal of developing a low-cost and highly scalable self-help tool to alleviate symptoms of PTSD. The app can be used on an iOS compatible phone and involves a training program that aims to directly reduce threat sensitivity by modifying attention. The contents of the app will be personalized for each user.
This self-help program is a placebo control program that will be used on an iOS compatible phone. The placebo will contain only neutral words.
This self-help program administered on an app will aim to reduce neurobiological threat sensitivity with the ultimate goal of a low-cost and highly scalable self-help tool to alleviate symptoms of PTSD. The app can be used on an iOS compatible phone and involves a training program that aims to directly reduce threat sensitivity by modifying attention. The contents of the app will be the same for each user.
Change in PTSD Checklist for DSM-5 (PCL-5) Score (Before/After Training)
Reported are the changes in the PTSD Checklist for the DSM-5 (PCL-5) scores between baseline (Day 1) and post-training (Day 14) in each group. The PCL-5 assesses the presence and severity of 20 different symptoms in posttraumatic stress disorder (PTSD). Each of the 20 items is scored on a severity range of 0 ("Not at All") to 4 ("Extremely"), for a final score range of 0 - 80. A score of 33 and above is indicative of clinically significant PTSD symptoms. Higher scores indicate worse PTSD symptom severity. A 10 point change (up or down) is considered a clinically significant change in PTSD symptoms.
Time frame: 2 weeks
Change in PTSD Checklist for DSM-5 (PCL-5) Scores (Follow-Up)
Reported are the changes in the PTSD Checklist for the DSM-5 (PCL-5) scores between post-training (Day 14) and follow-up (Day 56) in each group. The PCL-5 assesses the presence and severity of 20 different symptoms in posttraumatic stress disorder (PTSD). Each of the 20 items is scored on a severity range of 0 ("Not at All") to 4 ("Extremely"), for a final score range of 0 - 80. A score of 33 and above is indicative of clinically significant PTSD symptoms. Higher scores indicate worse PTSD symptom severity. A 10 point change (up or down) is considered a clinically significant change in PTSD symptoms.
Time frame: 6 weeks.
| Milestone | Personalized Attention Bias Training | Neutral Attention Training Condition | Non-Personalized Attention Bias Training |
|---|---|---|---|
| Started | 234 | 236 | 219 |
| Completed | 147 | 151 | 140 |
| Not completed | 87 | 85 | 79 |
Reported are the changes in the PTSD Checklist for the DSM-5 (PCL-5) scores between baseline (Day 1) and post-training (Day 14) in each group. The PCL-5 assesses the presence and severity of 20 different symptoms in posttraumatic stress disorder (PTSD). Each of the 20 items is scored on a severity range of 0 ("Not at All") to 4 ("Extremely"), for a final score range of 0 - 80. A score of 33 and above is indicative of clinically significant PTSD symptoms. Higher scores indicate worse PTSD symptom severity. A 10 point change (up or down) is considered a clinically significant change in PTSD symptoms.
| Scores on a scale | Personalized Attention Bias Training | Neutral Attention Training Condition | Non-Personalized Attention Bias Training |
|---|---|---|---|
| Change in PTSD Checklist for DSM-5 (PCL-5) Score (Before/After Training) | -8.67 ± 15.46 | -7.97 ± 14.93 | -10.41 ± 16.39 |
Reported are the changes in the PTSD Checklist for the DSM-5 (PCL-5) scores between post-training (Day 14) and follow-up (Day 56) in each group. The PCL-5 assesses the presence and severity of 20 different symptoms in posttraumatic stress disorder (PTSD). Each of the 20 items is scored on a severity range of 0 ("Not at All") to 4 ("Extremely"), for a final score range of 0 - 80. A score of 33 and above is indicative of clinically significant PTSD symptoms. Higher scores indicate worse PTSD symptom severity. A 10 point change (up or down) is considered a clinically significant change in PTSD symptoms.
| Scores on a scale | Personalized Attention Bias Training | Neutral Attention Training Condition | Non-Personalized Attention Bias Training |
|---|---|---|---|
| Change in PTSD Checklist for DSM-5 (PCL-5) Scores (Follow-Up) | 0.27 ± 15.86 | 0.05 ± 13.33 | -0.28 ± 14.09 |
Collected over From baseline assessment until the end of follow-up, approximately 6 weeks.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Personalized Attention Bias Training | 0/234 (0%) | 0/234 (0%) | 0/234 (0%) |
| Neutral Attention Training Condition | 0/236 (0%) | 0/236 (0%) | 0/236 (0%) |
| Non-Personalized Attention Bias Training | 0/219 (0%) | 0/219 (0%) | 0/219 (0%) |
Baseline characteristics were reported for all participants enrolled in the study who completed measures at Day 1 of training.
| Age, Continuous(Years) | Personalized Attention Bias Modification Training | Neutral Attention Bias Modification Training | Non-Personalized Attention Bias Modification Training | Total |
|---|---|---|---|---|
| Mean | 32.0 ± 10.0 | 32.0 ± 9.59 | 32.2 ± 10.1 | 32.1 ± 9.87 |
| Sex/Gender, Customized(Participants) | Personalized Attention Bias Modification Training | Neutral Attention Bias Modification Training | Non-Personalized Attention Bias Modification Training | Total |
|---|---|---|---|---|
| Sex — Male | 45 | 50 | 41 | 136 |
| Sex — Female | 188 | 186 | 177 | 551 |
| Sex — Missing | 1 | 0 | 1 | 2 |
| Race/Ethnicity, Customized(Participants) | Personalized Attention Bias Modification Training | Neutral Attention Bias Modification Training | Non-Personalized Attention Bias Modification Training | Total |
|---|---|---|---|---|
| Race/Ethnicity — African American/Black | 25 | 28 | 32 | 85 |
| Race/Ethnicity — American Indian/Alaskan | 0 | 1 | 2 | 3 |
| Race/Ethnicity — Asian | 21 | 16 | 20 | 57 |
| Race/Ethnicity — Caucasian/European American | 138 | 141 | 120 | 399 |
| Race/Ethnicity — Hawaiian/Pacific Islander | 1 | 0 | 0 | 1 |
| Race/Ethnicity — Hispanic/Latino | 28 | 34 | 27 | 89 |
| Race/Ethnicity — More than 1 ethnicity | 19 | 15 | 17 | 51 |
| Race/Ethnicity — Other | 1 | 1 | 1 | 3 |
| Race/Ethnicity — Missing | 1 | 0 | 0 | 1 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Nov 2017 to primary completion in Nov 2018, 11 months.
Results were first posted in Oct 2026, 7 years 11 months after primary completion.
Of 1,066 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's 11 months is below that.
Counting every sponsor, half of 1,094 studies reached it within 35 months; a quarter within 17 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stress Disorders, Post-Traumatic →
University of California, San Francisco →